Applied DNA Sciences, Inc. (APDN)
NASDAQ: APDN · Real-Time Price · USD
4.630
-0.306 (-6.20%)
At close: Jul 3, 2025, 1:00 PM
4.651
+0.021 (0.46%)
After-hours: Jul 3, 2025, 4:21 PM EDT
Applied DNA Sciences Employees
As of September 30, 2024, Applied DNA Sciences had 48 total employees, including 46 full-time and 2 part-time employees. The number of employees decreased by 7 or -12.73% compared to the previous year.
Employees
48
Change (1Y)
-7
Growth (1Y)
-12.73%
Revenue / Employee
$78,971
Profits / Employee
-$962,233
Market Cap
2.41M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
APDN News
- 3 days ago - Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx - Accesswire
- 16 days ago - Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward - Accesswire
- 17 days ago - Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August - Accesswire
- 5 weeks ago - Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025 - Accesswire
- 7 weeks ago - Applied DNA Reports Second Quarter Fiscal 2025 Financial Results - Accesswire
- 7 weeks ago - Applied DNA to Announce Second Quarter Fiscal 2025 Financial Results on May 15, Schedules Intra-Quarter Investor Update Call for June 3 - Accesswire
- 2 months ago - Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA - Accesswire
- 3 months ago - Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement - Accesswire